Genomic Data Analysis And Interpretation Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The genomic data analysis and interpretation market size has grown rapidly in recent years. It will grow from $1.14 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to the increasing proliferation of direct-to-consumer genetic testing services, rising public interest in genomics, the rapid development of next-generation sequencing (NGS) technologies, increasing integration of genomics into oncology practice, rising FDA approvals for genomic-based diagnostics and therapeutics.
The genomic data analysis and interpretation market size is expected to see rapid growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growth in research and development activities, rising adoption of high-throughput sequencing technologies, growing awareness and initiatives regarding genetic testing, and expanding applications of genomics in agriculture. Major trends in the forecast period include the integration of multi-omics data, AI and machine learning advancements, expansion of epigenomic analysis, shift towards cloud-based genomic data analysis platforms, and expansion in pharmacogenomics.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/genomic-data-analysis-and-interpretation-global-market-report
Scope Of Genomic Data Analysis And Interpretation MarketThe Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Genomic Data Analysis And Interpretation Market Overview
Market Drivers -The increasing number of cancer cases is expected to propel the growth of the genomic data analysis and interpretation market going forward. Cancer is the uncontrolled growth and spread of abnormal cells within the body, often infiltrating other tissues and organs. Cancer cases are rising due to an aging population, lifestyle changes including smoking and poor diet, environmental pollution, and improved detection methods leading to earlier diagnosis. Genomic data analysis and interpretation in cancer aid in identifying genetic mutations, biomarkers, and personalized treatment strategies for improved patient outcomes. For instance, in 2021, according to the American Cancer Society, a US-based community-based voluntary health organization, there were 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States 2021, an increase from 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in 2020. Therefore, the increasing number of cancer cases is driving the growth of the genomic data analysis and interpretation market.
Market Trends – Major companies operating in the genomic data analysis and interpretation market are focusing on developing innovative services, such as advanced long-read sequencing services, to gain a competitive edge in the market. Advanced long-read sequencing services involve cutting-edge technologies to analyze genetic material with longer sequence reads, allowing for more comprehensive and accurate characterization of DNA and RNA. For instance, in April 2024, Clinical-Microbiomics A/S, a Denmark-based biotechnology company, launched Advanced Long-Read 16S, ITS, 18S, Isolate, and metagenomics sequencing services. These services are intended to meet the needs of academic, clinical, and industrial researchers. These services provide higher-resolution insights into microbial communities by generating longer reads, which help distinguish between closely related organisms and link specific functions to these organisms. The data collected through long-read sequencing also supports the construction of high-quality metagenome-assembled genomes, providing a more precise and complete understanding of the microbial ecosystem.
The genomic data analysis and interpretation market covered in this report is segmented –
1) By Product: Software, Services
2) By Application: Functional Genomics, Real-time Polymerase Chain Reaction (PCR), Transfection, Single Nucleotide Polymorphisms (SNP) Analysis, Mutational Analysis, Microarray Analysis, Ribonucleic Acid (RNA) Interference, Pathway Analysis
3) By End User: Research And Academic Institutions, Biotechnology And Biopharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, Other End Users
Get an inside scoop of the genomic data analysis and interpretation market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15575&type=smp
Regional Insights – North America was the largest region in the genomic data analysis and interpretation market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic data analysis and interpretation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies – Major companies operating in the genomic data analysis and interpretation market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute (BGI) Genomics Co. Ltd, Guardant Health Inc., 10x Genomics Inc., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., SOPHiA GENETICS Inc., DNAnexus Inc., Seven Bridges Genomics Inc., ASURAGEN INC., Fabric Genomics Inc., DNASTAR Inc., Genoox, Golden Helix Inc., Partek Inc., SoftGenetics LLC, Cantada Bio, Geneyx Genomex Ltd., Freenome Holdings Inc, BlueBee Inc.
Table of Contents 1. Executive Summary2. Genomic Data Analysis And Interpretation Market Report Structure3. Genomic Data Analysis And Interpretation Market Trends And Strategies4. Genomic Data Analysis And Interpretation Market – Macro Economic Scenario5. Genomic Data Analysis And Interpretation Market Size And Growth…..27. Genomic Data Analysis And Interpretation Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
